New Drug Development: Design, Methodology, and Analysis

Forsideomslag
John Wiley & Sons, 27. jul. 2007 - 270 sider
This book acquaints students and practitioners in the related fields of pharmaceutical sciences, clinical trials, and evidence-based medicine with the necessary study design concepts and statistical practices to allow them to understand how drug developers plan and evaluate their drug development. Two goals of the book are to make the material accessible to readers with minimal background in research and to be straightforward enough for self-taught purposes. By bringing the topic from the early discovery phase to clinical trials and medical practice, the book provides an indispensable overview of an otherwise confusing and fragmented set of topics. The author’s experience as a respected scientist, teacher of statistics, and one who has worked in the clinical trials arena makes him well suited to write such a treatise.

Fra bogen

Indhold

Design Methodology and Analysis PART III DESIGN METHODOLOGY AND ANALYSIS
59
Design Methodology and Analysis PART IV LIFECYCLE CLINICAL DEVELOPMENT
137
Design Methodology and Analysis Appendix Additional Resources for Training Executives and Professors
241
Design Methodology and Analysis References
245
Design Methodology and Analysis Index
259
Design Methodology and Analysis About the Author
271
Copyright

Almindelige termer og sætninger

Om forfatteren (2007)

J. Rick Turner, PhD, is Chairman of the Department of Clinical Research at Campbell University School of Pharmacy in Morrisville, North Carolina. A Fellow of the Society of Behavioral Medicine, his areas of interest include cardiovascular behavioral medicine, drug development, and clinical submissions. Dr. Turner has authored several books as well as more than fifty articles in professional journals, and he received a Commit to Product Development Award from GlaxoSmithKline in 2005.

Bibliografiske oplysninger